Scientists test new weight Drug's safety with painkillers and heart meds
NCT ID NCT07269756
Summary
This early-stage study aims to understand how a new investigational drug for weight management, called HRS-7535, interacts with four common medications: acetaminophen (pain/fever), digoxin (heart), rosuvastatin (cholesterol), and omeprazole (heartburn). It will enroll 40 overweight or obese adults. The main goal is to see if taking HRS-7535 changes how the body processes these other drugs, which is a key safety step before larger trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Suzhou Municipal Hospital
RECRUITINGSuzhou, Jiangsu, 215000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.